Oncology & Cancer

New epigenetic drug against Mantle Cell Lymphoma

A new study by doctor Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of ...

Oncology & Cancer

Genetic test identifies 'high risk' lymphatic cancer patients

Around 1,500 people in Denmark are diagnosed with lymphatic cancer each year. A small sub-group (70 to 80 people) develop a rare and aggressive type of lymphatic cancer, known as mantle cell lymphoma (MCL).

Oncology & Cancer

Scientists identify genetic drivers of common lymphoma

An international team of scientists has pinpointed the genetic drivers of diffuse large B-cell lymphoma—the most common type of blood cancer—and determined the genes' clinical significance. The study, published in the ...

page 8 from 17